Developing vaccines to prevent HIV infection
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
This study is working on making new vaccines to help prevent HIV-1 infection, and it could lead to better ways to protect people from the virus in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11042023 on NIH RePORTER |
What this research studies
This research focuses on creating and manufacturing vaccines aimed at preventing HIV-1 infection. It involves developing various types of vaccines, including DNA plasmids, viral vectors, and protein antigens, and conducting preclinical testing to ensure their safety and effectiveness. Patients may benefit from this research as it aims to produce vaccines that could eventually be tested in human clinical trials, potentially leading to new prevention methods against HIV. The research also includes maintaining quality control and regulatory documentation to support the transition to clinical testing.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals at high risk of HIV exposure or those interested in preventive measures against HIV.
Not a fit: Patients who are already living with HIV or those who are not at risk of HIV exposure may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the risk of HIV infection.
How similar studies have performed: Previous research has shown promise in developing vaccines for HIV, but this approach aims to enhance the efficiency and speed of vaccine production and testing.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.